Walt Whitley, OD, MBA, FAAO: AbbVie/Allergan: Advisory Committee/Board Member (), Consulting Fees (); Alcon: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Aldeyra Therapeutics: Consulting Fees (); Apellis Pharmaceuticals: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Bausch + Lomb: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Bruder: Advisory Committee/Board Member (); Dompe: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Epion: Advisory Committee/Board Member (); Glaukos: Consulting Fees (); Harrow Pharmaceuticals: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); I2-Vision, Inc: Advisory Committee/Board Member (), Consulting Fees (); Iveric: Consulting Fees (); Lenz: Speaker's Bureau (honoraria or other compensation) (); Mediprint Pharma: Consulting Fees (), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (); Nordic Pharma: Consulting Fees (); Regener-Eyes: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (); Science Based Health: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Sight Sciences: Consulting Fees (); Sun Pharma: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Tarsus Pharma: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Trukera: Advisory Committee/Board Member (); Viatris: Consulting Fees (); Visus Therapeutics: Advisory Committee/Board Member ()
In a rapid fire format, this course will cover cases that are frequently referred to a tertiary referral clinic from ocular surgery to trauma to infectious disease. We will highlight the benefits of collaborative care by providing a variety of clinical cases and how these patients are properly treated and managed with the referring provider and other specialists.
Learning Objectives:
Upon conclusion of this activity, attendees will be able to:
Discuss the basis of optometric comanagement
Establish the role that ODs play in the comanagement of cataract and refractive surgery, glaucoma, retina, oculoplastics, neuro-ophthalmology, uveitis, and emergency eye care
Discuss pre/post-operative considerations for various ocular procedures
Evaluate current and future treatment options for various ocular conditions
